|
"liu chen hua"的相關文件
顯示項目 46-95 / 153 (共4頁)
1 2 3 4 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2018-09-10T07:37:25Z |
Peginterferon Alfa-2a Plus Ribavirin for the Treatment of Dual Chronic Infection With Hepatitis B and C Viruses
|
Liu, Chun-Jen;Chuang, Wan-Long;Lee, Chuan-Mo;Yu, Ming-Lung;Lu, Sheng-Nan;Wu, Shun-Sheng;Chen, Chi-Ling;Yang, Sien-Sing;Kao, Jia-Horng;Liu, Chen-Hua;Su, Wei-Wen;Jeng, Yung-Ming;Chen, Pei-Jer;Chen, Ding-Shinn; CHUN-JEN LIU; YUNG-MING JENG; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO; LIU, CHUN-JEN; CHUANG, WAN-LONG; LEE, CHUAN-MO; YU, MING-LUNG; LU, SHENG-NAN; WU, SHUN-SHENG; CHEN, CHI-LING; YANG, SIEN-SING; KAO, JIA-HORNG; LIU, CHEN-HUA; SU, WEI-WEN; JENG, YUNG-MING; CHEN, PEI-JER; CHEN, DING-SHINN |
| 臺大學術典藏 |
2018-09-10T07:35:34Z |
Hepatitis B virus basal core promoter mutation and DNA load correlate with expression of hepatitis B core antigen in patients with chronic hepatitis B
|
Liu, Chun-Jen;Jeng, Yung-Ming;Chen, Chi-Ling;Chen, Pei-Jer;Chen, Ting-Chi;Liu, Chen-Hua;Lai, Ming-Yang;Chen, Ding-Shinn;Kao, Jia-Horng; CHUN-JEN LIU; PEI-JER CHEN; YUNG-MING JENG; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO; LIU, CHUN-JEN; JENG, YUNG-MING; CHEN, CHI-LING; CHEN, PEI-JER; CHEN, TING-CHI; LIU, CHEN-HUA; LAI, MING-YANG; CHEN, DING-SHINN; KAO, JIA-HORNG |
| 臺大學術典藏 |
2018-09-10T07:35:33Z |
High serum adiponectin correlates with advanced liver disease in patients with chronic hepatitis B virus infection
|
Liu, Chun-Jen;Chen, Pei-Jer;Lai, Ming-Yang;Liu, Chen-Hua;Chen, Chi-Ling;Kao, Jia-Horng;Chen, Ding-Shinn; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO; LIU, CHUN-JEN; CHEN, PEI-JER; LAI, MING-YANG; LIU, CHEN-HUA; CHEN, CHI-LING; KAO, JIA-HORNG; CHEN, DING-SHINN |
| 臺大學術典藏 |
2018-09-10T06:58:57Z |
Regulation of floral organ abscission in Arabidopsis thaliana
|
Larue, C.T.; Chevalier, D.; Wang, H.; Jinn, T.-L.; Zhang, S.; Walker, J.C.; Cho, S. K.; Larue, C. T.; Chevalier, D.; Wang, H.; Jinn, T.-L.; Zhang, S.; Walker, J. C.; Sung, K.C.; Su, Tung-Hunget al.; Cho, S. K.; TSUNG-LUO JINN; Shiau, Chung-Wai; Larue, C. T.; Chevalier, D.; Jao, Ping; Wang, H.; Liu, Chen-Hua; Liu, Chun-Jen; Jinn, T.-L.; Zhang, S.; Tai, Wei-Tien; Jeng, Yung-Ming; Walker, J. C.; Yang, Hung-Chih; Tseng, Tai-Chung; Huang, Hsiang-Po; Cheng, Huei-Ru; Chen, Pei-Jer; Chen, Kuen-Feng; Kao, Jia-Horng; Chen, Ding-Shinn |
| 臺大學術典藏 |
2018-09-10T06:33:15Z |
Mucin 15 is expressed in human placenta and suppresses invasion of trophoblast-like cells in vitro
|
Chung, Chen-Shuan; JIN-CHUNG SHIH; Lin, Cheng-Kuan; CHIEN-NAN LEE; Su, Tung-Hung; Huang, J.; Liao, C.-H.; Yang, Hung-Chih; Liu, Chun-Jen; Huang, I-F.; Chen, Pei-Jer; Chen, H.-Y.; Huang, M.-C.; Chen, Ding-Shinn; Kao, Jia-Horng; Hsieh, F.-J.; MIN-CHUAN HUANG; Lin, M.-C.; Liu, Chen-Hua; Liang, Cheng-Chao; MING-KWANG SHYU; Shyu, M.-K.; Lin, M.-C.; Shih, J.-C.; Lee, C.-N.; Huang, J.; Liao, C.-H.; Huang, I-F.; Chen, H.-Y.; Huang, M.-C.; Hsieh, F.-J.; Shyu, M.-K. and Lin, M.-C. and Shih, J.-C. and Lee, C.-N. and Huang, J. and Liao, C.-H. and Huang, I.-F. and Chen, H.-Y. and Huang, M.-C. and Hsieh, F.-J. |
| 臺大學術典藏 |
2018-09-10T05:11:55Z |
Biliary hamartomas with delayed 99mTc-diisopropyl iminodiacetic acid clearance
|
Liu, C.-H. and Yen, R.-F. and Liu, K.-L. and Jeng, Y.-M. and Pan, M.-H. and Yang, P.-M.; 楊培銘;潘玫秀;鄭永銘;劉高郎;顏若芳;劉振驊; YANG, PEI-MING;PAN, MEI-HSIU;JENG, YUNG-MING;LIU, KAO-LANG;YEN, RUOH-FANG;LIU, CHEN-HUA; KAO-LANG LIU; Su, Tung-Hung; YUNG-MING JENG; Liu, Chun-Jen; Yang, Hung-Chih; CHEN-HUA LIU; PEI-MING YANG; Jeng, Yung-Ming; Cheng, Huei-Ru; Liu, Chen-Hua; YANG, PEI-MING; Tseng, Tai-Chung; PAN, MEI-HSIU; Ling, Thai-Yen; JENG, YUNG-MING; Chen, Pei-Jer; Chen, Ding-Shinn; LIU, KAO-LANG; YEN, RUOH-FANG; Kao, Jia-Horng; LIU, CHEN-HUA; ???w?H; ?L????; ?????; ??????; ??F??; ?B?T?H; ?????? |
| 臺大學術典藏 |
2018-09-10T05:02:40Z |
RBMY, a male germ cell-specific RNA-binding protein, activated in human liver cancers and transforms rodent fibroblasts
|
Tsuei, DJ;Hsu, HC;Lee, PH;Jeng, YM;Pu, YS;Chen, CN;Lee, YC;Chou, WC;Chang, CJ;Ni, YH;Chang, MH.; Tsuei, D.-J. and Hsu, H.-C. and Lee, P.-H. and Jeng, Y.-M. and Pu, Y.-S. and Chen, C.-N. and Lee, Y.-C. and Chou, W.-C. and Chang, C.-J. and Ni, Y.-H. and Chang, M.-H.; Liu, Chen-Hua; Tsuei, DJ; PO-HUANG LEE; Hsu, HC; Huang, Chung-Feng; MEI-HWEI CHANG; Lee, PH; Liu, Chun-Jen; CHIUNG-NIEN CHEN; YUNG-MING JENG; Dai, Chia-Yen; Jeng, YM; Yen-Hsuan Ni; Huang, Jee-Fu; Pu, YS; Chen, CN; Lin, Jou-Wei; YEONG-SHIAU PU; Lee, YC; Liang, Cheng-Chao; Chou, WC; Yang, Sheng-Shun; Lin, Chih-Lin; Chang, CJ; Su, Tung-Hung; Ni, YH; Yang, Hung-Chih; Chang, MH.; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Kao, Jia-Horng; Yu, Ming-Lung; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲; 林昭維 |
| 國立臺灣大學 |
2016 |
Hepatitis B Surface Antigen Loss and Hepatocellular Carcinoma Development in Patients With Dual Hepatitis B and C Infection
|
Yang, Wan-Ting; Wu, Li-Wei; Tseng, Tai-Chung; Chen, Chi-Ling; Yang, Hung-Chih; Su, Tung-Hung; Wang, Chia-Chi; Kuo, Stephanie Fang-Tzu; Liu, Chen-Hua; Chen, Pei-Jer; Chen, Ding-Shinn; Liu, Chun-Jen; Kao, Jia-Horng; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳祈玲 |
| 國立臺灣大學 |
2016 |
Prevalence and clinical implications of IL28B genotypes in Taiwanese patients with chronic hepatitis C
|
Mah, Yone-Han; Liu, Chen-Hua; Chen, Chi-Ling; Tseng, Tai-Chung; Liu, Chun-Jen; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 劉俊人; 陳培哲; 陳祈玲 |
| 國立臺灣大學 |
2016 |
Hepatitis C Viral Infection Increases the Risk of Lymphoid-Neoplasms: A Population-Based Cohort Study
|
Su, Tung-Hung; Liu, Chun-Jen; Tseng, Tai-Chung; Chou, Shih-Wan; Liu, Chen-Hua; Yang, Hung-Chih; Wu, Shang-Ju; Chen, Pei-Jer; Chen, Ding-Shinn; Chen, Chi-Ling; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲; 吳尚儒; 陳祈玲 |
| 國立臺灣大學 |
2016 |
Hepatocellular carcinoma recurrence after interferon-free direct acting antiviral treatment for chronic hepatitis C virus infection: fact or fiction?
|
Liu, Chen-Hua; Kao, Jia-Horng; 劉振驊; 高嘉宏 |
| 中國醫藥大學 |
2015-11 |
Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naive Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort Study
|
(Liu, Chen-Hua);(Sheng, Wang-Hui);(Sun, Hsin-Yun);(Hsieh, Szu-Min);(.....);洪健清(Chien-Ching Hung)*;(Kao, Jia-Horng) |
| 國立臺灣大學 |
2015 |
Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers
|
Tseng, Tai-Chung; Liu, Chun-Jen; Yang, Hung-Chih; Chen, Chi-Ling; Yang, Wan-Ting; Tsai, Cheng-Shiue; Kuo, Stephanie Fang-Tzu; Verbree, Femke Carolien; Su, Tung-Hung; Wang, Chia-Chi; Liu, Chen-Hua; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲; 陳祈玲 |
| 國立臺灣大學 |
2015 |
Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: a randomised trial
|
Liu, Chen-Hua; Liu, Chun-Jen; Huang, Chung-Feng; Lin, Jou-Wei; Dai, Chia-Yen; Liang, Cheng-Chao; Huang, Jee-Fu; Hung, Peir-Haur; Tsai, Hung-Bin; Tsai, Meng-Kun; Lee, Chih-Yuan; Chen, Shih-I; Yang, Sheng-Shun; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Yu, Ming-Lung; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 李志元; 劉俊人; 陳世宜; 陳培哲; 蔡孟昆; 林昭維; 蔡宏斌 |
| 國立臺灣大學 |
2015 |
Advanced Hepatic Fibrosis and Steatosis Are Associated With Persistent Alanine Aminotransferase Elevation in Chronic Hepatitis C Patients Negative for Hepatitis C Virus RNA During Pegylated Interferon Plus Ribavirin Therapy
|
Liang, Cheng-Chao; Liu, Chen-Hua; Chung, Chen-Shuan; Lin, Cheng-Kuan; Su, Tung-Hung; Yang, Hung-Chih; Liu, Chun-Jen; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲 |
| 國立臺灣大學 |
2015 |
Peginterferon plus weight-based ribavirin for treatment-naive hepatitis C virus genotype 2 patients not achieving rapid virologic response: a randomized trial
|
Liu, Chen-Hua; Huang, Chung-Feng; Liu, Chun-Jen; Dai, Chia-Yen; Huang, Jee-Fu; Lin, Jou-Wei; Liang, Cheng-Chao; Yang, Sheng-Shun; Lin, Chih-Lin; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Kao, Jia-Horng; Yu, Ming-Lung; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲; 林昭維 |
| 國立臺灣大學 |
2015 |
Comparison of Abbott RealTime HCV Genotype II with Versant Line Probe Assay 2.0 for Hepatitis C Virus Genotyping
|
Liu, Chen-Hua; Liang, Cheng-Chao; Liu, Chun-Jen; Lin, Chih-Lin; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲 |
| 國立臺灣大學 |
2015 |
Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Naive Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized Trial
|
Liu, Chen-Hua; Huang, Chung-Feng; Liu, Chun-Jen; Dai, Chia-Yen; Huang, Jee-Fu; Lin, Jou-Wei; Liang, Cheng-Chao; Yang, Sheng-Shun; Lin, Chih-Lin; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Kao, Jia-Horng; Yu, Ming-Lung; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲; 林昭維 |
| 國立臺灣大學 |
2015 |
Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naive Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort Study
|
Liu, Chen-Hua; Sheng, Wang-Hui; Sun, Hsin-Yun; Hsieh, Szu-Min; Lo, Yi-Chun; Liu, Chun-Jen; Su, Tung-Hung; Yang, Hung-Chih; Liu, Wen-Chun; Chen, Pei-Jer; Chen, Ding-Shinn; Hung, Chien-Ching; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 孫幸筠; 劉俊人; 謝思民; 陳培哲; 盛望徽; 洪健清 |
| 國立臺灣大學 |
2015 |
慢性C型肝炎病毒基因型第一型病患之優化治療
|
劉振驊; Liu, Chen-Hua |
| 國立臺灣大學 |
2015 |
Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibition
|
Su, Tung-Hung; Shiau, Chung-Wai; Jao, Ping; Liu, Chen-Hua; Liu, Chun-Jen; Tai, Wei-Tien; Jeng, Yung-Ming; Yang, Hung-Chih; Tseng, Tai-Chung; Huang, Hsiang-Po; Cheng, Huei-Ru; Chen, Pei-Jer; Chen, Kuen-Feng; Kao, Jia-Horng; Chen, Ding-Shinn; 陳定信; 劉振驊; 高嘉宏; 鄭永銘; 楊宏志; 蘇東弘; 陳昆鋒; 劉俊人; 陳培哲 |
| 國立臺灣大學 |
2015 |
Clinical significance of circulating miR-122 in patients with dual chronic hepatitis B and C virus infection
|
Cheng, Huei-Ru; Kao, Jia-Horng; Wu, Hui-Lin; Tseng, Tai-Chung; Liu, Chen-Hua; Yang, Hung-Chih; Su, Tung-Hung; Chen, Pei-Jer; Chen, Ding-Shinn; Liu, Chun-Jen; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲 |
| 國立臺灣大學 |
2015 |
Micro-evolution of the hepatitis B virus genome in hepatitis B e-antigen-positive carriers: Comparison of genotypes B and C at various immune stages
|
Liu, Chun-Jen; Chen, Ting-Chih; Chen, Pei-Jer; Wang, Hurng-Yi; Tseng, Tai-Chung; Cheng, Huei-Ru; Liu, Chen-Hua; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 劉俊人; 陳培哲; 王弘毅 |
| 國立臺灣大學 |
2015 |
Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients
|
Wang, Chia-Chi; Liu, Chen-Hua; Lin, Chih-Lin; Wang, Pin-Chao; Tseng, Tai-Chung; Lin, Hans Hsienhong; Kao, Jia-Horng; 劉振驊; 高嘉宏 |
| 國立臺灣大學 |
2015 |
Serum Biomarkers Predictive of Significant Fibrosis and Cirrhosis in Chronic Hepatitis B
|
Lin, Chih-Lin; Liu, Chen-Hua; Wang, Chia-Chi; Liang, Cheng-Chao; Su, Tung-Hung; Liu, Chun-Jen; Kao, Jia-Horng; 劉振驊; 高嘉宏; 蘇東弘; 劉俊人 |
| 國立臺灣大學 |
2015 |
The NIACE score helps predict the survival of Asian hepatocellular carcinoma patients
|
Su, Tung-Hung; Liu, Chun-Jen; Yang, Hung-Chih; Liu, Chen-Hua; Chen, Pei-Jer; Chen, Ding-Shinn; Adhoute, Xavier; Bourliere, Marc; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲 |
| 國立臺灣大學 |
2015 |
Benefits of Antiviral Treatment and Predictors of Subsequent Hepatocellular Carcinoma Risk in Chronic Hepatitis C Patients with or without Sustained Virological Response to Peg-interferon plus Ribavirin Therapy
|
Lee, Mei-Hsuan; Lu, Sheng-Nan; Yu, Ming-Lung; Peng, Cheng-Yuan; Sheen, I-Shyan; Liu, Chen-Hua; Kao, Jia-Horng; Chuang, Wan-Long; Yang, Hwai-I; L'Italien, Gilbert; Yuan, Yong; Chen, Chien-Jen; 劉振驊; 高嘉宏 |
| 國立交通大學 |
2014-12-08T15:29:51Z |
Association of IL28B genotypes with metabolic profiles and viral clearance rate in chronic hepatitis C patients
|
Hsu, Ching-Sheng; Hsu, Shih-Jer; Chen, Hung-Chia; Liu, Chen-Hua; Jeng, Jenher; Liu, Chun-Jen; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng |
| 國立交通大學 |
2014-12-08T15:12:03Z |
Association of IL28B gene variations with mathematical modeling of viral kinetics in chronic hepatitis C patients with IFN plus ribavirin therapy
|
Hsu, Ching-Sheng; Hsu, Shih-Jer; Chen, Hung-Chia; Tseng, Tai-Chung; Liu, Chen-Hua; Niu, Wei-Fang; Jeng, Jenher; Liu, Chun-Jen; Lai, Ming-Yang; Chen, Pei-Jer; Kao, Jia-Horng; Chen, Ding-Shinn |
| 臺北醫學大學 |
2014 |
Value of interleukin-28B genetic polymorphism on retreatment outcomes of chronic hepatitis C genotype 1 relapsers by peginterferon alfa plus ribavirin
|
Chen, Ming-Yao;Liu, Chen-Hua;Chen, Ting-Chih;Su, Tung-Hung;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng;Liu, Chun-Jen |
| 國立臺灣大學 |
2014 |
Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapy
|
Su, Tung-Hung; Liu, Chun-Jen; Yang, Hung-Chih; Jeng, Yung-Ming; Cheng, Huei-Ru; Liu, Chen-Hua; Tseng, Tai-Chung; Ling, Thai-Yen; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 劉振驊; 林泰元; 高嘉宏; 鄭永銘; 楊宏志; 蘇東弘; 劉俊人; 陳培哲 |
| 國立臺灣大學 |
2014 |
Inosine Triphosphatase and Interleukin 28B Genetic Variants to Predict Sustained Virologic Response in Hemodialysis Patients with Hepatitis C Virus Genotype 1 or 2 Infection who Received Peginterferon alfa-2a plus Low-Dose Ribavirin: Data Analysis from HELPER-1 and HELPER-2 Trials
|
Liu, Chen-Hua; Liu, Chun-Jen; Huang, Chung-Feng; Lin, Jou-Wei; Dai, Chia-Yen; Liang, Cheng-Chao; Huang, Jee-Fu; Hung, Peir-Haur; Tsai, Hung-Bin; Tsai, Meng-Kun; Lee, Chih-Yuan; Chen, Shih-I; Yang, Sheng-Shun; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Yu, Ming-Lung; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 李志元; 劉俊人; 陳世宜; 陳培哲; 蔡孟昆; 林昭維; 蔡宏斌 |
| 國立臺灣大學 |
2014 |
Clinical and virological features of occult hepatitis B in patients with HBsAg seroclearance post-treatment or spontaneously
|
Cheng, Huei-Ru; Kao, Jia-Horng; Wu, Hui-Lin; Chen, Ting-Chih; Tseng, Tai-Chung; Liu, Chen-Hua; Su, Tung-Hung; Chen, Pei-Jer; Chen, Ding-Shinn; Liu, Chun-Jen; 陳定信; 劉振驊; 高嘉宏; 吳慧琳; 蘇東弘; 劉俊人; 陳培哲 |
| 國立臺灣大學 |
2014 |
Serum cytokine/chemokine profiles in acute exacerbation of chronic hepatitis B: Clinical and mechanistic implications
|
Wu, Hui-Lin; Kao, Jia-Horng; Chen, Ting-Chih; Wu, Wen-Hsuan; Liu, Chen-Hua; Su, Tung-Hung; Yang, Hung-Chih; Chen, Ding-Shinn; Chen, Pei-Jer; Liu, Chun-Jen; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲 |
| 國立臺灣大學 |
2014 |
Value of interleukin-28B genetic polymorphism on retreatment outcomes of chronic hepatitis C genotype 1 relapsers by peginterferon alfa plus ribavirin
|
Chen, Ming-Yao; Liu, Chen-Hua; Chen, Ting-Chih; Su, Tung-Hung; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; Liu, Chun-Jen; 陳定信; 高嘉宏; 劉俊人; 陳培哲 |
| 國立臺灣大學 |
2014 |
A ten-year follow-up of patients with dual chronic hepatitis B and C virus infections: Outcomes and determinants
|
Liu, Chun-Jen; Tseng, Tai-Chung; Su, Tung-Hung; Yang, Hung-Chih; Liu, Chen-Hua; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 高嘉宏; 劉俊人; 陳培哲 |
| 國立臺灣大學 |
2014 |
Hepatitis B surface antigen level complements viral load in predicting viral reactivation in spontaneous HBeAg seroconverters
|
Tseng, Tai-Chung; Liu, Chun-Jen; Yang, Wan-Ting; Chen, Chi-Ling; Yang, Hung-Chih; Su, Tung-Hung; Wang, Chia-Chi; Kuo, Stephanie Fang-Tzu; Liu, Chen-Hua; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲; 陳祈玲 |
| 國立臺灣大學 |
2014 |
Nanomedicines in the treatment of hepatitis C virus infection in Asian patients: optimizing use of peginterferon alfae
|
Liu, Chen-Hua; Kao, Jia-Horng; 劉振驊; 高嘉宏 |
| 國立臺灣大學 |
2014 |
Significant Reduction of Hepatocellular Carcinoma Risk in Chronic Hepatitis C Patients with Peg-interferon plus Ribavirin Therapy: A Five-year Clinical Cohort Study
|
Lee, Mei-Hsuan; Yuan, Yong; Yu, Ming-Lung; Chuang, Wan-Long; Kao, Jia-Horng; Liu, Chen-Hua; Lu, Sheng-Nan; Sheen, I-Shyan; L'Italien, Gilbert J.; Yang, Hwai-I; Chen, Chien-Jen; 劉振驊; 高嘉宏 |
| 國立臺灣大學 |
2014 |
Patients with chronic hepatitis C virus infection have an increased risk of non-Hodgkin's lymphoma
|
Su, Tung-Hung; Liu, Chun-Jen; Chen, Chi-Ling; Tseng, Tai-Chung; Liu, Chen-Hua; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲; 陳祈玲 |
| 慈濟大學 |
2013 |
Serum hepatitis B surface antigen levels help predict disease progression in patients with low HBV loads Hepatology
|
Tseng, Tai?Chung;Liu, Chun?Jen;Yang, Hung?Chih;Su, Tung?Hung;Wang, Chia?Chi;Chen, Chi?Ling;Hsu, Cheng?An;Fang?Tzu Kuo, Stephanie;Liu, Chen?Hua;Chen, Pei?Jer |
| 國立臺灣大學 |
2013 |
Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion
|
Yang, Hung-Chih; Chen, Chi-Ling; Shen, Yueh-Chi; Peng, Cheng-Yuan; Liu, Chun-Jen; Tseng, Tai-Chung; Su, Tung-Hung; Chuang, Wan-Long; Yu, Ming-Lung; Dai, Chia-Yen; Liu, Chen-Hua; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲; 陳祈玲 |
| 國立臺灣大學 |
2013 |
Serum Hepatitis B Surface Antigen Levels Help Predict Disease Progression in Patients With Low Hepatitis B Virus Loads
|
Tseng, Tai-Chung; Liu, Chun-Jen; Yang, Hung-Chih; Su, Tung-Hung; Wang, Chia-Chi; Chen, Chi-Ling; Hsu, Cheng-An; Kuo, Stephanie Fang-Tzu; Liu, Chen-Hua; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲; 陳祈玲 |
| 國立臺灣大學 |
2013 |
Serum microRNA-122 level correlates with virologic responses to pegylated interferon therapy in chronic hepatitis C
|
Su, Tung-Hung; Liu, Chen-Hua; Liu, Chun-Jen; Chen, Chi-Ling; Ting, Te-Tien; Tseng, Tai-Chung; Chen, Pei-Jer; Kao, Jia-Horng; Chen, Ding-Shinn; 陳定信; 劉振驊; 高嘉宏; 蘇東弘; 劉俊人; 陳培哲; 陳祈玲 |
| 國立臺灣大學 |
2013 |
Association of IL28B genotypes with metabolic profiles and viral clearance rate in chronic hepatitis C patients
|
Hsu, Ching-Sheng; Hsu, Shih-Jer; Chen, Hung-Chia; Liu, Chen-Hua; Jeng, Jenher; Liu, Chun-Jen; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 徐士哲; 劉俊人; 陳培哲 |
| 國立臺灣大學 |
2013 |
Longitudinal Change of HBsAg in HBeAg-negative Patients with Genotype B or C Infection
|
Su, Tung-Hung; Liu, Chun-Jen; Tseng, Tai-Chung; Liu, Chen-Hua; Yang, Hung-Chih; Chen, Chi-Ling; Chen, Pei-Jer; Kao, Jia-Horng; Chen, Ding-Shinn; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲; 陳祈玲 |
| 國立臺灣大學 |
2013 |
Profound week 4 interferon responsiveness is mandatory for hepatitis C genotype 1 patients with unfavorable IL-28B genotype
|
Huang, Chung-Feng; Yu, Ming-Lung; Kao, Jia-Horng; Tseng, Tai-Chung; Yeh, Ming-Lun; Huang, Jee-Fu; Dai, Chia-Yen; Lin, Zu-Yau; Chen, Shinn-Cherng; Wang, Liang-Yen; Juo, Suh-Hang Hank; Chuang, Wan-Long; Liu, Chen-Hua; 劉振驊; 高嘉宏 |
| 國立臺灣大學 |
2013 |
Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up
|
Yu, Ming-Lung; Lee, Chuan-Mo; Chen, Chi-Ling; Chuang, Wan-Long; Lu, Sheng-Nan; Liu, Chen-Hua; Wu, Shun-Sheng; Liao, Li-Ying; Kuo, Hsing-Tao; Chao, You-Chen; Tung, Shui-Yi; Yang, Sien-Sing; Kao, Jia-Horng; Su, Wei-Wen; Lin, Chih-Lin; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Liu, Chun-Jen; 陳定信; 劉振驊; 高嘉宏; 劉俊人; 陳培哲; 陳祈玲 |
| 國立臺灣大學 |
2013 |
Comparison Between Patients With Hepatocellular Carcinoma and Hepatitis C in Fatigue and Psychological Distress Before Receiving Treatment
|
Shun, Shiow-Ching; Lai, Yeur-Hur; Liu, Chen-Hua; 劉振驊 |
| 國立臺灣大學 |
2013 |
Risk Stratification of Hepatocellular Carcinoma in Hepatitis B Virus e Antigen-Negative Carriers by Combining Viral Biomarkers
|
Tseng, Tai-Chung; Liu, Chun-Jen; Chen, Chi-Ling; Yang, Hung-Chih; Su, Tung-Hung; Wang, Chia-Chi; Yang, Wan-Ting; Kuo, Stephanie Fang-Tzu; Liu, Chen-Hua; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 劉俊人; 陳培哲; 陳祈玲 |
顯示項目 46-95 / 153 (共4頁)
1 2 3 4 > >>
每頁顯示[10|25|50]項目
|
